~India's Path to Improved Vision through State-of-the-Art Technology~
17th August 2023, National: ZEISS Medical Technology, which remains committed to driving progress, efficiency, and access to healthcare technology, supporting doctors to improve their patients' quality of life, has seen a significant rise in the adoption of SMILE (Small Incision Lenticule Extraction) technology in India. As a groundbreaking and minimally invasive vision correction procedure, ZEISS SMILE (Small Incision Lenticule Extraction) procedures have experienced fast growth in the Indian market, revolutionizing the way people address refractive errors and achieve clearer vision.
ZEISS SMILE represents a paradigm shift in laser eye surgery, providing patients with a reliable and precise solution to common vision problems such as myopia (nearsightedness) and astigmatism. Since its introduction to the Indian market in 2008, ZEISS SMILE has garnered widespread attention and acceptance from both eye care professionals and patients due to its unique advantages and transformative benefits.
In the past 10 years, 200,000+ eyes have been successfully treated by ZEISS SMILE procedures in India. Globally, ZEISS has facilitated 8 million + SMILE procedures.
Key features and benefits of ZEISS SMILE technology include:
- Minimally Invasive Procedure: ZEISS SMILE requires only a tiny incision, typically around 2mm, making it a minimally-invasive and flapless laser eye surgery. This helps to reduce the risk of complications and contributes to a quicker recovery for patients.
- Enhanced Safety: The procedure involves the use of femtosecond laser technology, which allows for precise and gentle treatment. With its high level of safety, ZEISS SMILE has been widely recognized as a well-suited option for a broad range of patients across all professions and lifestyles, particularly for defense and military personnel, athletes of all levels, people in the fashion industry, university students and prospective brides to name a few. Faster Recovery: Patients can experience faster visual recovery with ZEISS SMILE compared to traditional LASIK procedures. Many individuals report improved vision almost immediately after the surgery.
- High Precision: ZEISS SMILE employs cutting-edge laser technology, enabling eye care professionals to achieve an exceptionally accurate and predictable outcome in vision correction.
- Reduced Dry Eye Incidence: As ZEISS SMILE does not require the creation of a corneal flap, it may lead to a reduced occurrence of dry eye symptoms, offering a more comfortable post-operative experience for patients.
“I believe, Lenticule Extraction with ZEISS SMILE is one of the paths to a sharp vision. With over a decade of outstanding experience, our Center proudly endorses ZEISS SMILE as a solution for laser refractive correction. Our patients consistently report great visual outcomes and long-term stability without unwanted after-effects such as residual dry eye. SMILE stands out as the preferred choice, empowering individuals to swiftly resume their regular lifestyle merely days after the procedure. I wholeheartedly recommend SMILE to every eligible individual seeking freedom from glasses.” said Dr. Aadithreya Varman, Director, Uma Eye Clinic
“Within the realm of ophthalmology, the SMILE procedure stands as a remarkable testament to the blend of innovation and best patient outcome. I believe as surgeons our commitment extends beyond just correcting refractive errors; it is about creating a brighter world for each individual who entrusts us. Through surgical precision, SMILE is carving pathways to clearer sight and enhanced quality of life. I recommend SMILE to those who are eligible for Refractive Surgery, especially for athletes and sports enthusiasts as it avoids flap-related complications and ensures fast recovery. It is a minimally invasive, painless and flapless technique for the Myopic population as well as for individuals with milder forms of Astigmatism. SMILE has been delivering a good experience for me and my patients. I feel this technique is the future of Refractive Surgery.” said Dr Ramya Sampath, Regional Head - Clinical Services, Dr. Agarwal Eye Clinic
As ZEISS SMILE continues to gain popularity, it represents a significant advancement in the field of vision correction. Its precision, safety, and quick recovery times make it a compelling choice for both eye care professionals and patients who are seeking a reliable and effective solution for their refractive errors. With its ongoing growth and adoption in India and around the world, ZEISS SMILE is reshaping the way people achieve a clearer vision and improving the quality of life for countless individuals.
ZEISS Medical Technology division is committed to working closely with Indian eye care professionals to expand access to ZEISS SMILE technology and ensure the best possible patient outcomes in the region.
By collaborating with leading eye care professionals, reputable clinics and eye centers, ZEISS aims to ensure that more individuals can benefit from this cutting-edge procedure for vision correction.
About ZEISS Group:
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 8.8 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2022).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.
With over 38,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 30 September 2022). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com
No comments:
Post a Comment